SI

Saberaben Iliyas Batti

Active Director Designated Partner DIN 07808246
DIN 07808246 First appointment May 2017 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Saberaben Iliyas Batti

Data last updated:

Saberaben Iliyas Batti is a Designated Partner at Al Ardh Bio Refining And Chemicals Llp (since 2017). The company operates in Chemicals.

DIN 07808246
Primary Designation Designated Partner
Industry Chemicals
First Appointment 16 May 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 May 20172017Active

Board colleagues of Saberaben Iliyas Batti

NameDINCompanyDesignation
Iliyas Ismailbhai Batti07808362Al Ardh Bio Refining And Chemicals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Al Ardh Bio Refining And Chemicals Llp
Premium access

Shareholding and investment profile for Saberaben Iliyas Batti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saberaben Iliyas Batti

Saberaben Iliyas Batti currently holds 1 directorship: Al Ardh Bio Refining And Chemicals Llp (Designated Partner, since 16 May 2017).

Saberaben Iliyas Batti was first appointed on 16 May 2017 as Designated Partner at Al Ardh Bio Refining And Chemicals Llp.

The current boards of Saberaben Iliyas Batti's companies include Iliyas Ismailbhai Batti (Al Ardh Bio Refining And Chemicals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available